Checkpoint Therapeutics logo
Checkpoint Therapeutics CKPT
$ 3.11 -3.12%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Checkpoint Therapeutics Financial Ratios 2011-2025 | CKPT

Annual Financial Ratios Checkpoint Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.7 -0.5 -0.2 -7.9 -2.6 -3.0 -4.0 -10.6 - - - - -

P/S

353.0 170.7 50.8 169.7 37.4 30.9 52.4 92.2 - - - - -

EPS

-3.2 -7.1 -7.5 -0.4 -0.7 -1.3 -1 -1.0 -1.4 - - - -

EV (Enterprise Value)

49.9 M 53.5 M -15.1 M 148 M 45.9 M 99.3 M 77.6 M 206 M -46.2 M - - - -

EBITDA per Share

-2.78 -6.6 -7.46 -0.416 -0.704 -1.29 -1 -1.03 - - - - -

EV/EBITDA

-0.8 -6.1 -1.5 -2.3 -3.1 -9.1 - - - - -

PEG

-0.0 -0.0 -0.0 -0.19 -0.06 0.11 -1.04 0.13 - - - - -

P/B

-2.8 -1.7 0.5 5.1 3.4 9.2 6.0 7.3 - - - - -

P/CF

-0.8 -0.6 -0.5 -11.0 -3.0 -4.2 -5.7 -18.1 - - - - -

ROE %

397.39 321.43 -190.51 -65.24 -131.13 -308.04 -150.77 -69.53 - - - - -

ROA %

-964.06 -471.21 -101.69 -54.19 -91.65 -146.06 -105.90 -62.43 - - - - -

ROCE %

399.69 299.40 -190.69 -65.58 -131.85 -311.20 -151.42 -68.61 - - - - -

Current Ratio

0.3 0.4 2.1 5.9 3.3 1.9 3.4 9.8 - - - - -

DSO

- - - 6.8 5.6 159.5 70.0 116.6 - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
20232023202220222021202120202020201920192018201820172017201620162015201520142014201320132012201220112011600 600 300 300 0 0 -300 -300 -600 -600 -900 -900 -1200 -1200
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Quarterly Financial Ratios Checkpoint Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.23 -0.18 - -0.29 -1.05 -0.89 - -1.2 -1.62 -1.98 - -0.14 -0.12 -0.09 - -0.09 -0.09 -0.06 - -0.15 -0.15 -0.18 -0.37 -0.32 -0.23 -0.35 -0.26 -0.26 -0.28 -0.2 -0.38 -0.24 -0.25 -0.17 -0.55 -0.44 -0.06 -0.2 - - - - - - - - - - - - - - - -

EBITDA per Share

-0.23 -0.18 - -0.39 -1.03 -1.54 - -1.2 -1.62 -1.98 - -0.14 -0.12 -0.09 - -0.09 -0.09 -0.07 - -0.15 -0.15 -0.18 - -0.32 -0.23 -0.35 - -0.26 -0.28 -0.2 - -0.24 -0.25 -0.16 - -0.43 - - - - - - - - - - - - - - - - - -

ROE %

179.71 173.47 148.28 943.19 1708.03 1447.52 522.05 498.56 -319.83 -146.39 -51.57 -65.50 -55.95 -53.01 -36.34 -63.96 -77.65 -89.94 -84.30 -182.72 -234.24 -265.05 -308.04 -248.97 -209.23 -195.87 -150.77 -137.19 -113.65 -87.51 -69.53 -61.12 -53.32 -36.59 -25.43 -8.08 - - - - - - - - - - - - - - - - - -

ROA %

-821.55 -831.92 -633.86 -682.94 -473.96 -319.89 -132.43 -150.91 -120.30 -90.05 -42.89 -54.47 -47.57 -44.64 -30.18 -49.49 -57.22 -64.08 -58.92 -105.58 -123.80 -132.70 -146.06 -127.03 -117.19 -120.64 -105.90 -101.40 -87.97 -72.88 -62.43 -55.19 -48.34 -33.32 -23.30 -7.40 - - - - - - - - - - - - - - - - - -

ROCE %

200.49 192.85 191.57 990.37 1748.73 1489.32 525.58 502.07 -320.24 -146.53 -51.64 -65.62 -56.08 -53.19 -36.63 -64.40 -78.20 -90.60 -84.86 -164.37 -216.11 -247.06 -210.47 -250.03 -210.08 -196.54 -111.93 -127.84 -104.19 -77.93 -42.81 -50.74 -42.76 -25.99 -7.93 -7.93 - - - - - - - - - - - - - - - - - -

Current Ratio

0.3 0.3 0.3 0.1 0.3 0.2 0.4 0.9 1.3 1.9 2.1 4.7 7.2 8.5 5.9 5.9 5.9 5.9 3.3 3.3 3.3 3.3 1.9 1.9 1.9 1.9 3.4 3.4 3.4 3.4 9.8 9.8 9.8 9.8 11.9 11.9 - - - - - - - - - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency